Ilumina (ILMN -3.6%) slips today on a Baird dowgrade to Neutral. Baird says there are near-term...

|By:, SA News Editor

Ilumina (ILMN -3.6%) slips today on a Baird dowgrade to Neutral. Baird says there are near-term M&A risks, specifically citing ILMN's own bid for Complete Genomics (GNOM +0.2%) while chatter resurfaces about Roche (RHHBY.OB) potentially trying to buy ILMN again after falling to reach a deal earlier this year.